company background image
A6X logo

aXichem DB:A6X Stock Report

Last Price

€0.076

Market Cap

€6.9m

7D

3.2%

1Y

-11.6%

Updated

24 Apr, 2025

Data

Company Financials

A6X Stock Overview

A biotechnology company, engages in the development of natural analogue ingredients in Sweden. More details

A6X fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

aXichem AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for aXichem
Historical stock prices
Current Share PriceSEK 0.076
52 Week HighSEK 0.12
52 Week LowSEK 0.056
Beta-0.37
1 Month Change-2.30%
3 Month Change7.91%
1 Year Change-11.57%
3 Year Change-94.99%
5 Year Change-98.44%
Change since IPO-98.36%

Recent News & Updates

Recent updates

Shareholder Returns

A6XDE ChemicalsDE Market
7D3.2%4.1%3.6%
1Y-11.6%-5.4%11.2%

Return vs Industry: A6X underperformed the German Chemicals industry which returned -7.3% over the past year.

Return vs Market: A6X underperformed the German Market which returned 9.5% over the past year.

Price Volatility

Is A6X's price volatile compared to industry and market?
A6X volatility
A6X Average Weekly Movement28.3%
Chemicals Industry Average Movement7.0%
Market Average Movement6.3%
10% most volatile stocks in DE Market12.7%
10% least volatile stocks in DE Market3.1%

Stable Share Price: A6X's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: A6X's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of German stocks.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

FoundedEmployeesCEOWebsite
19997Torsten Helsingwww.axichem.com

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.

aXichem AB Fundamentals Summary

How do aXichem's earnings and revenue compare to its market cap?
A6X fundamental statistics
Market cap€6.87m
Earnings (TTM)-€1.63m
Revenue (TTM)€784.37k

8.8x

P/S Ratio

-4.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A6X income statement (TTM)
RevenueSEK 8.57m
Cost of RevenueSEK 1.49m
Gross ProfitSEK 7.08m
Other ExpensesSEK 24.89m
Earnings-SEK 17.81m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 22, 2025

Earnings per share (EPS)-0.30
Gross Margin82.63%
Net Profit Margin-207.85%
Debt/Equity Ratio0%

How did A6X perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/24 18:10
End of Day Share Price 2025/04/24 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

aXichem AB is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan SvantessonRedeye